首页|Department of Pathology Reports Findings in Breast Cancer (The prediction of pCR and chemosensitivity for breast cancer patients using DLG3, RADL and Pathomics signatures based on machine learning and deep learning)
Department of Pathology Reports Findings in Breast Cancer (The prediction of pCR and chemosensitivity for breast cancer patients using DLG3, RADL and Pathomics signatures based on machine learning and deep learning)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology - Breast Canc er is the subject of a report. According to news originating from Xiangtan, Peop le’s Republic of China, by NewsRx correspondents, research stated, “Limited stud ies have investigated the predictive value of multiomics signatures (radiomics, deep learning features, pathological features and DLG3) in breast cancer patient s who underwent neoadjuvant chemotherapy (NAC). However, no study has explored t he relationships among radiomic, pathomic signatures and chemosensitivity.”
XiangtanPeople’s Republic of ChinaAsiaBreast CancerCancerChemotherapyCyborgsDrugs and TherapiesEmerging TechnologiesHealth and MedicineMachine LearningOncologyWomen’s Health
NETL
NSTL
